AEON Biopharma, Inc. (AEON) vs IN8bio, Inc. (INAB)
- AEON Biopharma, Inc. AEON 0.23 −4.17%
- IN8bio, Inc. INAB 1.11 −6.72%
AEON Biopharma, Inc. and IN8bio, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and IN8bio, Inc. are of similar size ($12.1M and $11.7M). Across the 8 metrics below, IN8bio, Inc. leads on 5 and AEON Biopharma, Inc. on 3.
Valuation
Profitability
| Metric | AEON | INAB | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 350.00% | (111.11%) | (56.36%) |
| Return on assets | (621.70%) | (90.80%) | (48.04%) |
| Return on invested capital | 0.00% | (2,948.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack